This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
Severn Trent (SVT.L) - reported a 7% rise in annual underlying pre-tax profit to £269.1m, beating analyst consensus. Said it was paying a dividend of 80.4p for the 2013/14 financial year, a 6%. Closing price 1933p. (Reuters)
Tate & Lyle (TATE.L) - Reported lower full-year earnings on Thursday, hurt by a dramatic drop in prices of its sucralose sweetener and weak sales of soft drinks in the United States. Operating profit was £349m in the year ended 31st March, down 2% from the prior year. Closing price 674.5p. (Reuters)
Kingfisher (KGF.L) - Posted a 20 % surge in first quarter retail profit and said it would pay a £100m special dividend as part of its new plans for extra shareholder rewards. Retail profit rose to £142m, just below a company compiled consensus forecast of £145m. Closing price 417.3p. (Reuters)
Paypoint (PAY.L) – Full-year profit before tax £46.0m versus £41.3m. Says final dividend of 23.9p, up 18.3p%. Closing price 1050p. (Reuters)
Centrica (CNA.L) - The chiefs of British Gas and its parent company, Centrica, are close to stepping down as part of a management shake-up at Britain's biggest energy supplier. Closing price 330.8p. (Reuters)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| Firstgroup | FGP.L | 0.15% | 0.94% | -1.23% |
| Serco | SRP.L | 4.06% | 4.47% | 0.03% |
| Weir Group | WEIR.L | -0.77% | 2.00% | -2.23% |
| De La Rue | DLAR.L | 7.90% | 9.26% | 0.57% |
| Glaxosmithkline | GSK.L | -1.59% | -0.92% | -1.93% |
| Morrisons | MRW.L | -0.56% | 0.10% | -1.40% |
| Telford Homes | TELF.L | 2.87% | 5.32% | 1.07% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research